Search Results - taylor+riall

1 Results

Sort By:

Identification of P53-activating Compounds for Cancer Research and Therapy

C03857: Cell line to identify inhibitors of p53 Technical Details: An exciting, new invention from the laboratory of Dr. Scott Kern at The Johns Hopkins University School of Medicine for the identification of p53 activating compounds that would be of interest to In Vitro Technologies. The status of p53 varies among human tumors and has been associated...

Published: 7/4/2024 | Inventor(s): Taylor Riall, Scott Kern

Keywords(s): Basic Research Biomarker, Biomarker, Cancers, Cloning Reagents, Discovery/Research Tools, Disease Indication, Oncogene, Pharmakodynamic Biomarker, Research Reagent, Single, Targeted Therapy, Therapeutic Matter, Therapeutics, Therapy Type

Category(s): Clinical and Disease Specializations, Clinical and Disease Specializations > Oncology, Technology Classifications > Diagnostics > Biomarkers, Technology Classifications > Research Tools > Nucleic Acids, Technology Classifications > Therapeutic Modalities > Targets, Technology Classifications > Diagnostics, Technology Classifications > Research Tools, Technology Classifications > Therapeutic Modalities